Recognizing that the available participant population for rare disease studies is often extremely limited and dispersed globally, GSK welcomed an innovative approach to expanding trial access—one that ...
Xlife Sciences AG / Key word (s): Expansion/IPO Xlife Sciences AG Announces the listing of FUSE-AI GmbH on the London Stock Exchange in the First Half of 2025 21-Nov-2024 / 07:00 CET/CEST Release of ...
Extensive research has indicated the benefits of showing gratitude to those around you, including your colleagues or employees. However, a new study suggests that the timing of these expressions can ...